Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Troxacitabine

EU orphan designation number: EU/3/05/311
Active ingredient: Troxacitabine
Indication: Treatment of acute myeloid leukaemia
Sponsor: Pharm Research Associates (UK) Limited
Pacific House, Imperial Way, Reading, Berkshire RG2 0TD, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
05/09/2005 Centralised Orphan - Designation EMEA/OD/045/05 (2005)3318 of 26/08/2005
22/03/2007 Centralised Orphan - Transfer of orphan designation EMEA/OD/045/05/T/01 (2007)1319 of 20/03/2007
14/01/2008 Centralised Orphan - Removal of orphan designation from Community Register